Joining our Talent Network allows you to connect with our recruitment team and stay up to date about exciting career opportunities with our team.
ABOUT INTERCEPT:
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs.
People at Intercept are passionate about patients. You’ll see our patient photos lining our walls and hear their stories in town halls. We’re equally passionate about our team, ensuring each member feels included and has the opportunity to reach their potential. We recognize the power of an equal opportunity work force, and how it enriches the professional lives of our team members. Equal opportunity drives innovation and connects us to the patients and communities we serve.
For more information about Intercept, please visit our website at: and follow us on X at: @InterceptPharma.
Requirements
This posting is not tied to a specific job opening.
Benefits
TOTAL REWARDS:
Intercept also provides a competitive suite of benefits, including:
- 401(k) plan with company match
- Rewards and recognition program
- Health care benefits (medical, prescription drugs, dental, and vision insurance)
- Short and long-term disability coverage provided
- Plan coverage for domestic partners
- Paid parental leave benefits and adoption assistance
- Tuition reimbursement assistance
- A generous Paid Time Off program that includes 20 vacation days, 11 holidays, 4 personal days, and 2 volunteer days per calendar year
- Numerous well-being and work/life programs
What We Do
We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH).
In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs.
Our corporate headquarters is located in New Jersey.
For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on X at: @InterceptPharma.
